Medicine guide
Ultratard
·
- Prescription status not stated
- Digestion, stomach, diabetes and nutrition
- Active substance
- Insulin human (rDNA)
- Made by
- Novo Nordisk A/S
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Treatment of diabetes mellitus.
From the official label · 2026-09-30 · European Medicines Agency
Details
| Made by | Novo Nordisk A/S |
|---|---|
| Active substance | Insulin human (rDNA) |
| Used in | Digestion, stomach, diabetes and nutrition |
| Classification | A10AE01 · Digestion, stomach, diabetes and nutrition |
| Authorised on | 2002-10-07 |
| Last updated by the regulator | 2008-02-14 |
| EMA product number | EMEA/H/C/000439 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.
ActraphaneEU authorisation Novo Nordisk A/S · Insulin human (rDNA) · A10AD01MixtardEU authorisation Novo Nordisk A/S · Insulin human (rDNA) · A10AD01InpremziaEU authorisation Baxter Holding B.V. · Insulin human (rDNA) · A10AB01InsulatardEU authorisation Novo Nordisk A/S · Insulin human (rDNA) · A10AC01ProtaphaneEU authorisation Novo Nordisk A/S · Insulin human (rDNA) · A10AC01VelosulinEU authorisation Novo Nordisk A/S · Insulin human (rDNA) · A10AB01